Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging.

Date publication

décembre 2021

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Dr EYMARD Jean-Christophe , Pr PIOT Olivier

Tous les auteurs :
Mazza C, Gaydou V, Eymard JC, Birembaut P, Untereiner V, Côté JF, Brocheriou I, Coeffic D, Villena P, Larré S, Vuiblet V, Piot O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35008184

Résumé

Neoadjuvant chemotherapy (NAC) improves survival in responder patients. However, for non-responders, the treatment represents an ineffective exposure to chemotherapy and its potential adverse events. Predicting the response to treatment is a major issue in the therapeutic management of patients, particularly for patients with muscle-invasive bladder cancer.

Mots clés

chemometric algorithms, mid-infrared imaging, muscle-invasive bladder cancer, neoadjuvant chemotherapy, predictive response to treatment

Référence

Cancers (Basel). 2021 Dec 21;14(1):